Neuroprotection against excitotoxicity by N-alkylglycines in rat hippocampal neurons

NeuroMolecular Medicine

Volumn 2, Issue 3, 2002, Pages 271-280

  Valera, Elvira ^a   Fernández Salguero, Pedro M ^a   Planells Cases, Rosa ^b   Messeguer, Angel ^c   Van Den Nest, Wim ^d   Carreño, Cristina ^d   Ferrer Montiel, Antonio ^b   Merino, Jaime M ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^c CSIC   (Spain)

^d DiverDrugs SL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; AMYLOID BETA PROTEIN; DIZOCILPINE; GLUCOSE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; GLYCINE; GLYCINE DERIVATIVE; MEMANTINE; N (3,3 DIPHENYLPROPYL)GLYCINAMIDE; N (3,3 DIPHENYLPROPYL)GLYCYL N [3 (2 OXO N PYRROLIDINYL)PROPYL]GLYCYL N [2 (METHYLCARBONYLAMINO)ETHYL]GLYCINAMIDE; N (3,3 DIPHENYLPROPYL)GLYCYL N [3 (N,N DIETHYLAMINO)PROPYL]GLYCINAMIDE; N (3,3 DIPHENYLPROPYL)GLYCYL N [3 (N,N DIETHYLAMINO)PROPYL]GLYCYL N [2 (METHYLCARBONYLAMINO)ETHYL]GLYCINAMIDE; N [2 (N PYRROLIDINYL)ETHYL]GLYCYL N (CYCLOPROPYL)GLYCYL N (SEC BUTYL)GLYCINAMIDE; N [2 [2 (N METHYL)PYRROLIDINYL]ETHYL]GLYCYL N [2,4 (DICHLOROPHENYL)ETHYL]GLYCYL N [2,4 (DICHLOROPHENYL)ETHYL]GLYCINAMIDE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N161515C; N20197C; N2019C; N20C; N612C; NEUROPROTECTIVE AGENT; REACTIVE OXYGEN METABOLITE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; AMINO ACID RECEPTOR BLOCKING AGENT; DRUG DERIVATIVE; NEUROTOXIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL DEATH; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG TARGETING; EMBRYO; HIPPOCAMPUS; NERVE CELL CULTURE; NEUROLOGIC DISEASE; NEUROPHARMACOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SYNTHESIS; ANIMAL; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; FETUS; METABOLISM; NERVE CELL; RAT;

ANIMALIA; HIPPOCAMPUS HIPPOCAMPUS;

AMYLOID BETA-PROTEIN; ANIMALS; CELLS, CULTURED; EXCITATORY AMINO ACID ANTAGONISTS; FETUS; GLUTAMIC ACID; GLYCINE; HIPPOCAMPUS; NEURODEGENERATIVE DISEASES; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; RATS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0038777272     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1385/NMM:2:3:271     Document Type: Article

References (20)

1. Choi, D. W. and Rothman, S. M. (1990) The role of glutamate neuro toxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13, 171-182.
2. Ankarcrona, M., Dypbukt, J. M., Bonfoco, E., et al. (1995) Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15, 961-973.
3. Nicotera, P., Ankarcrona, M., Bonfoco, E., Orrenius, S., and Lipton, S. A. (1997) Neuronal necrosis and apoptosis: two distinct events induced by exposure to glutamate or oxidative stress. Adv. Neurol. 72, 96-101.
4. Garthwaite, J. (1995) NMDA receptors, neuronal development, and neurodegeneration, in The NMDA receptor (Ed. Collingridge, G.L.), Oxford University Press, Oxford, pp. 428-457.
5. Chase, T. N. and Oh, J. D. (2000) Striatal mechanisms and pathogenesis of parkinsonian signs and motor complications. Ann. Neurol. 47 (Suppl. 1), 122-129.
6. Heintz, N. and Zoghbi, H. Y. (2000) Insights from mouse models into the molecular basis of neurodegeneration. Annu. Rev. Physiol. 62, 779-801.
7. Choi, D. W. (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623-634.
8. Choi, D. W. (1995) Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci. 18, 58-60.
9. Collingridge, G. L. and Lester, R. A. J. (1989) Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol. Rev. 40, 143-210.
10. Ferrer-Montiel, A., Merino, J. M., Blodelle, S. E., et al. (1998) Selected peptides targeted to the NMDA receptor channel protect neurons from excitotoxic death. Nature Biotechnol. 16, 286-291.
11. During, M. J., Symes, C. W., Lawlor, P. A., et al. (2000) An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. Science 287, 1453-1460.
12. Tai, K. K., Blondelle, S. E., Ostresh, J. M., Houghten, R. A., and Montal, M. (2001) An N-methyl-D-aspartate receptor channel blocker with neuroprotective activity. Proc. Natl. Acad. Sci. USA 98, 3519-3524.
13. Monaghan, D. T. and Cotman, C. W. (1985) Distribution of N-methyl-D-aspartate sensitive L-[3H]glutamate binding sites in rat brain. J. Neurosci. 5, 2909-2919.
14. Planells-Cases, R., Montoliu, C., Humet, M., et al. (2002) Identification and characterization of an N-alkylglycine-based NMDA receptor open channel blocker with in vivo neuroprotectant activity. J. Pharmacol. Exp. Ther. 302, 163-173.
15. Mattson, M. P., Chan, S. L., and Duan, W. (2002) Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior. Physiol. Rev. 82, 637-672.
16. Selkoe, D. J. (1989) Biochemistry of altered brain proteins in Alzheimer's disease. Annu. Rev. Neurosci. 12, 463-490.
17. Yankner, B. A., Duffy, L. K., and Kirschner, D. A. (1990) Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250, 279-282.
18. Montoliu, C., Humet, M., Cannales, J. J., et al. (2002) Prevention of in vivo excitotoxicity by a family of trialkylglycines, a novel class of neuroprotectants. J. Pharmacol. Exp. Ther. 301, 29-36.
19. Brauner-Osborne, H., Egebjerg, J., Nielsen, E. O., Madsen, U., and Krogsgaard-Larsen, P. (2000) Ligands for glutamate receptors: design and therapeutic prospects. J. Med. Chem. 43, 2609-2645.
20. Martin, R. L., Lloyd, H. G., and Cowan, A. I. (1994) The early events of oxygen and glucose deprivation: setting the scene for neuronal death? Trends Neurosci. 17, 251-257.